127 related articles for article (PubMed ID: 3469275)
1. Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiation.
Momburg F; Möller P; Moldenhauer G; Hämmerling GJ
J Immunogenet; 1986; 13(2-3):195-9. PubMed ID: 3469275
[TBL] [Abstract][Full Text] [Related]
2. Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.
Momburg F; Degener T; Bacchus E; Moldenhauer G; Hämmerling GJ; Möller P
Int J Cancer; 1986 Feb; 37(2):179-84. PubMed ID: 2417962
[TBL] [Abstract][Full Text] [Related]
3. Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.
Stein B; Momburg F; Schwarz V; Schlag P; Moldenhauer G; Möller P
Br J Cancer; 1988 Apr; 57(4):364-8. PubMed ID: 2839218
[TBL] [Abstract][Full Text] [Related]
4. Selective loss of HLA-A,B,C locus products in colorectal adenocarcinoma.
Smith ME; Bodmer WF; Bodmer JG
Lancet; 1988 Apr; 1(8589):823-4. PubMed ID: 2895339
[No Abstract] [Full Text] [Related]
5. Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence.
Möller P; Koretz K; Schlag P; Momburg F
Int J Cancer Suppl; 1991; 6():155-62. PubMed ID: 1712347
[TBL] [Abstract][Full Text] [Related]
6. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
[TBL] [Abstract][Full Text] [Related]
7. Loss of polymorphic A and B locus HLA antigens in colon carcinoma.
Rees RC; Buckle AM; Gelsthorpe K; James V; Potter CW; Rogers K; Jacob G
Br J Cancer; 1988 Apr; 57(4):374-7. PubMed ID: 3291922
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HLA class I gene expression in human colorectal carcinoma.
Soong TW; Oei AA; Hui KM
Semin Cancer Biol; 1991 Feb; 2(1):23-33. PubMed ID: 1912515
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.
Durrant LG; Ballantyne KC; Armitage NC; Robins RA; Marksman R; Hardcastle JD; Baldwin RW
Br J Cancer; 1987 Oct; 56(4):425-32. PubMed ID: 3689659
[TBL] [Abstract][Full Text] [Related]
10. Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans.
Umpleby HC; Heinemann D; Symes MO; Williamson RC
J Natl Cancer Inst; 1985 Jun; 74(6):1161-8. PubMed ID: 3158771
[TBL] [Abstract][Full Text] [Related]
11. The membrane antigens of human colorectal cancer cells: demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR.
Daar AS; Fabre JW
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):209-20. PubMed ID: 6337854
[TBL] [Abstract][Full Text] [Related]
12. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
Momburg F; Möller P
Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
[TBL] [Abstract][Full Text] [Related]
13. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
Degener T; Momburg F; Möller P
Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
[TBL] [Abstract][Full Text] [Related]
15. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
Smith ME; Marsh SG; Bodmer JG; Gelsthorpe K; Bodmer WF
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5557-61. PubMed ID: 2473473
[TBL] [Abstract][Full Text] [Related]
16. Identification of locus-specific DNA-binding factors for the regulation of HLA class-I genes in human colorectal cancer.
Soong TW; Hui KM
Int J Cancer Suppl; 1991; 6():131-7. PubMed ID: 2066178
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA-D sub-region products on human colorectal carcinoma.
Ghosh AK; Moore M; Street AJ; Howat JM; Schofield PF
Int J Cancer; 1986 Oct; 38(4):459-64. PubMed ID: 2428757
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunoperoxidase demonstration of T-antigens in human colorectal carcinomas and morphologically abnormal mucosa.
Orntoft TF; Mors NP; Eriksen G; Jacobsen NO; Poulsen HS
Cancer Res; 1985 Jan; 45(1):447-52. PubMed ID: 3880667
[TBL] [Abstract][Full Text] [Related]
19. HLA antigens in colorectal cancers and adenomas.
Hiwatashi N; Kikuchi T; Masamune O; Ouchi E; Watanabe H; Goto Y
Tohoku J Exp Med; 1980 Jul; 131(3):257-60. PubMed ID: 7414607
[TBL] [Abstract][Full Text] [Related]
20. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].
Esteban F; Concha A; Delgado M; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(6):359-68. PubMed ID: 2092725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]